source Post navigation First-Ever Oral GLP-1 Drug Achieves Major Diabetes Breakthrough: Lilly Reports 1.6% A1C Drop in Phase 3 – Stock Titan Lilly's oral GLP-1 succeeds in first Phase III test – FirstWord Pharma